Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity.

ABSTRACT:

Purpose

This study aimed to report on our institutional experience in the use of stereotactic body radiation therapy (SBRT) for the treatment of adrenal gland metastases. Specifically, we examined the outcomes and toxicity from this treatment modality on adjacent organs at risk.

Methods and materials

Data were retrieved from patients with adrenal metastases who were treated with SBRT between 2008 and 2017. Patients with primary adrenal malignancies were excluded. Toxicities were graded in accordance with the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.03. Time-to-event rates were calculated from the date of SBRT delivery.

Results

In total, 35 patients with adrenal metastases were identified. Four patients were treated for bilater

SUBMITTER: Toesca DAS 

PROVIDER: S-EPMC6200881 | biostudies-literature | 2018 Oct-Dec

REPOSITORIES: biostudies-literature